Skip to Main Content

Paper Details

Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination.
Nat Med
268
2022
Author NameAffiliation
Carolina LucasYale University School of Medicine
Chantal B F VogelsYale School of Public Health
Inci YildirimYale School of Public Health
Inci YildirimYale Institute for Global Health, Yale University
Inci YildirimYale University School of Medicine
Claire Pearson
Albert I KoYale School of Public Health
Albert I KoYale University School of Medicine
Albert I KoInstituto Goncalo Moniz
Saad B OmerYale School of Public Health
Saad B OmerYale Institute for Global Health, Yale University
Saad B OmerYale University School of Medicine
Nathan D GrubaughYale School of Public Health
Nathan D GrubaughYale University
Akiko IwasakiMinistry of Health
Akiko IwasakiHoward Hughes Medical Institute
  • 1 - 16

Datasets

Release 1.2